Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Does This Billion-Dollar Deal Solve Pfizer's Biggest Problem?
02:00pm, Tuesday, 14'th Mar 2023
Pfizer reached a record $100 billion in revenue last year, thanks to its coronavirus portfolio. But a decline in vaccine demand and competition ahead for some of Pfizer's other top products is set to
Is Pfizer Stock a Screaming Buy After Its $43 Billion Seagen Acquisition?
11:45am, Tuesday, 14'th Mar 2023
Pfizer has been a stock in search of a catalyst all year long. The drugmaker's $43 billion acquisition of Seagen probably isn't the catalyst shareholders were hoping for.
Pfizer (PFE) to Buy Seagen for $43B, Boost Cancer Portfolio
11:26am, Tuesday, 14'th Mar 2023
Pfizer (PFE) is set to buy Seagen (SGEN) in a $43 billion deal. Seagen's key products focus on cancer treatment.
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
10:44am, Tuesday, 14'th Mar 2023
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
How Pfizer's $43 billion acquisition of Seagen could impact the biotech industry in Seattle
09:52pm, Monday, 13'th Mar 2023
Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed.
Week Ahead: Banking Crisis, Inflation Reports, and Big Pharma Acquisitions
05:34pm, Monday, 13'th Mar 2023
Last week ended on a hectic note
Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion
04:41pm, Monday, 13'th Mar 2023
Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pha
Pfizer offers $43 billion to buy cancer drugmaker Seagen
03:24pm, Monday, 13'th Mar 2023
CNBC's Meg Tirrell joins 'Power Lunch' to discuss Pfizer's acquisition of Seagen, the reasoning behind the $43 billion biotech deal, and more.
Pfizer CEO says it will be able to deliver Seagen's cancer therapy at a scale not seen before with $43 billion deal
01:48pm, Monday, 13'th Mar 2023
Pfizer CEO Albert Bourla said it will deliver Seagen's cancer therapy to the world at a scale that hasn't been seen before with its $43 billion acquisition.
Pfizer Overpays for Seagen, but Who's Counting
01:37pm, Monday, 13'th Mar 2023
Acquiring top biotech assets as other big pharmaceutical companies face a patent cliff was bound to be expensive.
Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret
12:58pm, Monday, 13'th Mar 2023
Zavzpret (zavegepant) is now part of Pfizer's (PFE) migraine drugs portfolio with the 2022 acquisition of Biohaven. Zavzpret provides migraine patients access to a fast-acting pain-relief option.
Seagen has one of the greatest technologies to battle cancer: Pfizer CEO on acquisition
12:25pm, Monday, 13'th Mar 2023
Albert Bourla, Pfizer CEO, joins 'Squawk on the Street' to discuss his thoughts on the company buying Seagen.
Pfizer Buying Seagen For $43 Billion: Details (PFE) (SGEN)
12:09pm, Monday, 13'th Mar 2023
Pfizer (NYSE: PFE) is buying Seagen Inc. (Nasdaq: SGEN) for $43 billion. These are the details.
Pfizer to pay $43B for Seagen, boosting cancer drug portfolio
11:58am, Monday, 13'th Mar 2023
The latest deal comes as Pfizer seeks to mitigate an anticipated $17 billion hit to revenue by 2030 from patent expirations for top drugs and decline in demand for its COVID products.
Pfizer aiming to acquire Seagen in $43 billion deal
11:37am, Monday, 13'th Mar 2023
Yahoo Finance Live's Julie Hyman discusses reports that Pfizer is aiming to acquire Seagen in a $43 billion deal.
